Haier Biomedical and Resonant launch an R290 centrifuge ahead of tighter F-gas restrictions in Europe and the US
Impact level
⚪ Background
What happened
On October 7, 2026, Resonant Clinical Solutions and Haier Biomedical jointly launched the LX-60T100R benchtop centrifuge, which uses the natural hydrocarbon refrigerant R290 and is intended for clinical trial settings. Its refrigerant GWP is reduced from over 1,400 for conventional F-gas systems to about 3. The 220–240V model is available to buy or rent immediately; the 110V model is planned for release in the first quarter of 2027. Until November 2027, clinical trial sponsors and CROs can purchase or rent the product only through Resonant. The exclusive agreement covers the global clinical trial market, excluding China. [1] [2]
Involves:Benchtop centrifuge LX-60T100R、Natural hydrocarbon refrigerant R290
Seller impact
- FactThe product is claimed to meet upcoming restrictions on fluorinated greenhouse gases (F-gases) in Europe and the US more than two years ahead of schedule. Compliance requirements may become a factor in equipment selection for laboratory buyers; however, the source does not specify the regulations, effective dates, or limits, so the scope of the actual restrictions is unknown. [1]
- InferenceInference: R290 is a flammable refrigerant. If the target markets have stricter requirements for hydrocarbon refrigerant charge limits or laboratory safety certifications, this could increase certification and installation costs and limit channel expansion. There are currently no data on refrigerant charge, certification standards, or pricing, so the scale of the impact is unknown. [1]
Suggested action
Sellers of laboratory equipment can check the name and effective date of the F-gas regulations applicable to this model in their target countries, then assess stocking or alternatives once they have confirmed the compliance timeline.
Evidence that would disprove the assessment
- Assessment 1:If the relevant F-gas regulations in Europe and the US do not impose this type of restriction on laboratory centrifuges, or take effect after 2028, the “early compliance” selling point does not hold.
- Assessment 2:If official specifications show that the refrigerant charge is below the applicable limit for flammable refrigerants and that the product has obtained the relevant certifications in Europe and the US, this assessment of cost and channel constraints would no longer apply. Recheck the product specifications page over the next two weeks.